ArticleOncotarget2016

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.

Ann-Katrin Sommer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.